Press Release 3 - July 2006

BioAnaLab, the specialist contract research organisation providing analytical services to the biotechnology and pharmaceutical industry, is pleased to announce the appointment of David Oxlade as Chairman of the Board of Directors with effect from 14th July 2006. David Oxlade is an experienced health care business executive; until recently a Director and Chief Executive of Xenova Group plc, David is also a Non-Executive Director of Cobra Biomanufacturing plc.  During his career, David has been involved in the development of a number of public and private innovative healthcare businesses in Europe, North America and Asia. Prior to joining the Xenova Group, David held managerial and Board level positions with several international and global companies, including that of President of Syva Company, the California based subsidiary of Hoechst AG, ICI Diagnostics, Boehringer Mannheim GmbH (now part of Roche) and Glaxo Research.  Commenting on the appointment, Professor Geoff Hale, Chief Executive Officer of BioAnaLab, said: ‘We are delighted to welcome David Oxlade to the Board as Chairman of BioAnaLab. His significant experience and background in corporate development in the international health care business is very relevant to BioAnaLab’s plans for growth in this dynamic global sector.’ David Oxlade added: 'Since its foundation in 2002, BioAnaLab has shown excellent growth, especially in the field of biologics. The increasingly complex nature of modern medicines is creating a greater need for specialist analytical services such as BioAnaLab provides. The Company has established a reputation for high quality and an efficient service for its customers, thanks to its dedicated team of scientists, which positions BioAnaLab well for its next stage of its development.' Contact Information: BioAnaLab:Professor Geoff Hale, Chief Executive Officer,                  Tel: +44(0)1865 784470 For further information please see www.bioanalab.com About BioAnaLab

BioAnaLab is an MHRA-accredited contract analytical laboratory which specializes in the analysis of biologic drugs like monoclonal antibodies, recombinant proteins and vaccines. It provides services to the worldwide pharmaceutical industry, as well as to clinical investigators, mainly in the analysis and characterization of drugs and the measurement of drug levels in the body and immune responses.

BioAnaLab Limited,

The Magdalen Centre,

Oxford Science Park

Oxford OX4 4GA